Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sanofi India Limited ( (IN:SANOFI) ) has provided an update.
Sanofi India Limited has notified the stock exchanges that it has made available the transcript of its investor and analyst call held on 26 February 2026, covering the financial results for the quarter and year ended 31 December 2025. The disclosure, made in line with SEBI’s listing regulations and posted on the company’s website, underscores Sanofi India’s ongoing commitment to transparency and timely communication with investors and other market participants.
More about Sanofi India Limited
Sanofi India Limited is a pharmaceutical company operating in India, focusing on the development, manufacturing and marketing of healthcare and prescription drug products. The company serves both domestic and international markets and is listed on major Indian stock exchanges, reflecting its role as a significant player in the country’s healthcare sector.
Average Trading Volume: 1,125
Technical Sentiment Signal: Hold
Current Market Cap: 88.93B INR
For a thorough assessment of SANOFI stock, go to TipRanks’ Stock Analysis page.